Healthcare Costs

As National Disability Employment Awareness Month kicks off, a new virtual challenge forces companies to rethink accessible wellness and the disabled workforce.

As open enrollment approaches, consumers face a 15% rate hike, a $12,000 out-of-pocket cliff, and widespread insurer exits that demand active market navigation.

Illume Fertility's recent work at the Men Having Babies conference highlights the complex financial, clinical, and regulatory hurdles in LGBTQ+ family building.

Invivyd's VYD2311 beats mRNA vaccines on tolerability and boosts immunity, but regulatory and economic hurdles loom large for the novel therapy.

Azurity's newly approved liquid lamotrigine isn't just a convenience—it's a critical safety measure for pediatric epilepsy and bipolar patients facing high risks.

Ontario’s decision to fund a targeted adult pneumococcal vaccine offers a vital shield for seniors while easing the severe strain on our hospital systems.

J&J's CARVYKTI shows half of early-line myeloma patients achieve five-year remissions. But does a functional cure justify the severe upfront risks?

MyOme’s integration with Oracle Cloud marks a strategic shift in preventive healthcare, moving from single-use panels to lifetime genomic risk re-querying.

New 2026 data reveals America's disconnection is a systemic crisis. Discover why time, distance, and a lack of physical infrastructure are the true culprits.

A landmark California ruling exposes algorithmic health insurer reimbursements to state antitrust laws, threatening automated pricing models nationwide.

Ozari Health’s new top ranking highlights a shift toward supply chain transparency, but regulatory hurdles and hidden costs complicate the weight-loss boom.

Türkiye’s first proton therapy center at Çam ve Sakura City Hospital proves that shrinking medical tech is the key to expanding global cancer care access.

MedAxiom's CV Transforum Fall '26 winners reveal how AI-guided diagnostics, remote monitoring, and automated workflows are solving the cardiology workforce crisis.

As the global population ages, advanced adult briefs are transforming home healthcare. Discover the hidden costs and high-tech solutions driving a $30B market.

Kinomatic and March 2 A Million are partnering to eliminate opioids from joint replacement recovery. But does this mission-driven venture mask a corporate funnel?

As U.S. health systems rush to adopt generative AI, a new partnership between Tech Mahindra and Verato aims to solve the multi-billion-dollar identity data problem undermining digital health.

A new predictive AI model reduces major fall injuries by 75%, but scaling it exposes deep economic and workforce fractures in the home care industry.

As U.S. fertility clinics launch aggressive roadshows across Greater China, we examine the strategic use of regulatory arbitrage and influencer marketing.

As hospital-payer disputes surge and AI claims denials cost billions, Big Law is aggressively recruiting specialized litigators to protect provider margins.

Corridor’s $25M launch reveals how autonomous AI agents are dismantling the legacy broker model to bring enterprise-level healthcare savings to Main Street.